These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 24968355)
1. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2. Hsieh TC; Lin CY; Bennett DJ; Wu E; Wu JM PLoS One; 2014; 9(6):e101070. PubMed ID: 24968355 [TBL] [Abstract][Full Text] [Related]
2. Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells. Hsieh TC; Yang CJ; Lin CY; Lee YS; Wu JM Carcinogenesis; 2012 Mar; 33(3):670-7. PubMed ID: 22266466 [TBL] [Abstract][Full Text] [Related]
3. In silico and biochemical analyses identify quinone reductase 2 as a target of piceatannol. Hsieh TC; Bennett DJ; Lee YS; Wu E; Wu JM Curr Med Chem; 2013; 20(33):4195-202. PubMed ID: 23992305 [TBL] [Abstract][Full Text] [Related]
4. The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties. Megarity CF; Gill JR; Caraher MC; Stratford IJ; Nolan KA; Timson DJ FEBS Lett; 2014 May; 588(9):1666-72. PubMed ID: 24631540 [TBL] [Abstract][Full Text] [Related]
5. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases. Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934 [TBL] [Abstract][Full Text] [Related]
6. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells. Cai JB; Zhang ZH; Xu DJ; Qian ZY; Wang ZR; Huang YZ; Zou JG; Cao KJ Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1419-25. PubMed ID: 18671725 [TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells. Hsieh TC Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309 [TBL] [Abstract][Full Text] [Related]
8. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT. Leung KK; Shilton BH Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648 [TBL] [Abstract][Full Text] [Related]
11. NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis. Dorai T; Shah A; Summers F; Mathew R; Huang J; Hsieh TC; Wu JM Prostate; 2018 Nov; 78(15):1181-1195. PubMed ID: 30009389 [TBL] [Abstract][Full Text] [Related]
12. Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems. Yan C; Dufour M; Siegel D; Reigan P; Gomez J; Shieh B; Moody CJ; Ross D Biochemistry; 2011 Aug; 50(31):6678-88. PubMed ID: 21718050 [TBL] [Abstract][Full Text] [Related]
13. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. Alarma-Estrany P; Crooke A; Pintor J J Pineal Res; 2009 Sep; 47(2):201-209. PubMed ID: 19627460 [TBL] [Abstract][Full Text] [Related]
14. NRH:quinone oxidoreductase 2 (NQO2) protein competes with the 20 S proteasome to stabilize transcription factor CCAAT enhancer-binding protein α (C/EBPα), leading to protection against γ radiation-induced myeloproliferative disease. Xu J; Patrick BA; Jaiswal AK J Biol Chem; 2013 Nov; 288(48):34799-808. PubMed ID: 24142791 [TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition. Dufour M; Yan C; Siegel D; Colucci MA; Jenner M; Oldham NJ; Gomez J; Reigan P; Li Y; De Matteis CI; Ross D; Moody CJ Chembiochem; 2011 May; 12(8):1203-8. PubMed ID: 21506232 [TBL] [Abstract][Full Text] [Related]
16. The effect of resveratrol and its methylthio-derivatives on the Nrf2-ARE pathway in mouse epidermis and HaCaT keratinocytes. Krajka-Kuźniak V; Szaefer H; Stefański T; Sobiak S; Cichocki M; Baer-Dubowska W Cell Mol Biol Lett; 2014 Sep; 19(3):500-16. PubMed ID: 25169438 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of quinone reductase 2 in complex with resveratrol. Buryanovskyy L; Fu Y; Boyd M; Ma Y; Hsieh TC; Wu JM; Zhang Z Biochemistry; 2004 Sep; 43(36):11417-26. PubMed ID: 15350128 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Hsieh TC; Wang Z; Hamby CV; Wu JM Biochem Biophys Res Commun; 2005 Aug; 334(1):223-30. PubMed ID: 15993843 [TBL] [Abstract][Full Text] [Related]
19. Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-ones. Dunstan MS; Barnes J; Humphries M; Whitehead RC; Bryce RA; Leys D; Stratford IJ; Nolan KA J Med Chem; 2011 Oct; 54(19):6597-611. PubMed ID: 21859103 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibits angiotensin II-induced ERK1/2 activation by downregulating quinone reductase 2 in rat vascular smooth muscle cells. Zhang X; Wang Y; Yang W; Hou X; Zou J; Cao K J Biomed Res; 2012 Mar; 26(2):103-9. PubMed ID: 23554738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]